Roberts, Glore & Co’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-4,930
Closed -$468K 150
2018
Q3
$468K Sell
4,930
-225
-4% -$19.2K 0.27% 93
2018
Q2
$398K Buy
5,155
+170
+3% +$12.8K 0.24% 98
2018
Q1
$344K Sell
4,985
-50
-1% -$3.81K 0.21% 107
2017
Q4
$376K Sell
5,035
-2,225
-31% -$142K 0.23% 98
2017
Q3
$460K Sell
7,260
-3,280
-31% -$204K 0.3% 85
2017
Q2
$673K Sell
10,540
-6,460
-38% -$406K 0.45% 67
2017
Q1
$1.12M Sell
17,000
-1,030
-6% -$70.9K 0.77% 42
2016
Q4
$1.24M Buy
18,030
+825
+5% +$59.1K 0.86% 37
2016
Q3
$1.21M Buy
17,205
+2,040
+13% +$153K 0.87% 40
2016
Q2
$1.15M Buy
15,165
+5,390
+55% +$396K 0.87% 36
2016
Q1
$671K Buy
9,775
+770
+9% +$55.4K 0.51% 58
2015
Q4
$787K Sell
9,005
-200
-2% -$17.1K 0.6% 51
2015
Q3
$745K Buy
+9,205
New +$802K 0.58% 49

Other funds holding ESRX

Roberts, Glore & Co's ESRX Position: Q4 2018 in Review

Roberts, Glore & Co sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 4,930 shares — an estimated $468K sold.

Roberts, Glore & Co first reported a position in ESRX in Q3 2015 and held it in 13 quarters. The position peaked at $1.24M in Q4 2016. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Roberts, Glore & Co reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Roberts, Glore & Co sold 4,930 Express Scripts Holding Company shares in Q4 2018, an estimated $468K.
  • Roberts, Glore & Co first reported a position in Express Scripts Holding Company in Q3 2015 and held it in 13 quarters.
  • Roberts, Glore & Co's Express Scripts Holding Company position peaked at $1.24M in Q4 2016.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Roberts, Glore & Co's 13F filing for Q4 2018, filed 8 Feb 2019.